This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Horizon Pharma PLC (HZNP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 218.81M 80.48M 104.09M 17.97M
Receivables 73.92M 15.96M 3.46M 2.37M
Inventories 16.86M 10.02M 5.24M 1.20M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 326.22M 110.76M 116.92M 25.05M
Property, Plant & Equipment, Gross 11.19M 6.43M 5.23M 4.02M
Accumulated Depreciation & Depletion 3.95M 2.65M 1.51M 771.00K
Property, Plant & Equipment, Net 7.24M 3.78M 3.72M 3.24M
Intangibles 770.83M 131.09M 68.89M 72.24M
Other Non-Current Assets 11.56M 6.96M 4.45M 547.00K
Total Non-Current Assets 808.40M 141.83M 77.07M 76.03M
Liabilities & Shareholder Equity
Total Assets 1.13B 252.60M 193.98M 101.08M
Accounts Payable 21.01M 9.92M 5.99M 8.17M
Short Term Debt 48.33M 0.00 0.00 0.00
Other Current Liabilities 13.67M 755.00K 52.00K 196.00K
Total Current Liabilities 219.39M 43.31M 36.94M 23.98M
Long Term Debt 297.17M 110.76M 36.87M 15.83M
Deferred Income Taxes 19.57M 3.36M 4.41M 9.56M
Other Non-Current Liabilities 58.29M 144.24M 9.80M 5.79M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 375.03M 258.37M 51.07M 31.18M
Total Liabilities 594.42M 301.68M 88.01M 55.17M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 540.20M -49.08M 105.98M 45.91M
Common Par 13.00K 7.00K 6.00K 2.00K
Additional Paid In Capital 1.27B 410.43M 417.46M 270.02M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -720.72M -457.12M -308.11M -220.32M
Treasury Stock -4.58M 0.00 0.00 0.00
Other Equity Adjustments -4.36M -2.40M -3.37M -3.79M
Total Capitalization 837.37M 61.68M 142.84M 61.75M
Total Equity 540.20M -49.08M 105.98M 45.91M
Total Liabilities & Stock Equity 1.13B 252.60M 193.98M 101.08M
Total Common Shares Outstanding 124.04M 66.10M 61.72M 19.63M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 384.37K 0.00 0.00 0.00
Basic Weighted Shares Outstanding 83.75M 63.66M 38.87M 9.01M
Diluted Weighted Shares Outstanding 83.75M 63.66M 38.87M 9.01M
Number of Employees 535 304 247 164
Number of Part-Time Employees 0 0 0 0

HZNP Horizon Pharma PLC

Chart of HZNP

Analysts Ratings for HZNP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 8 8
Moderate Buy 1 1 1 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

HZNP Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs